Advertisement
Singapore markets closed

  • Straits Times Index

    3,144.76
    -38.85 (-1.22%)
     

  • S&P 500

    5,056.22
    -5.60 (-0.11%)
     

  • Dow

    37,835.68
    +100.57 (+0.27%)
     

  • Nasdaq

    15,880.11
    -4.90 (-0.03%)
     

  • Bitcoin USD

    62,155.80
    -2,351.68 (-3.65%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • FTSE 100

    7,817.04
    -148.49 (-1.86%)
     

  • Gold

    2,395.80
    +12.80 (+0.54%)
     

  • Crude Oil

    85.55
    +0.14 (+0.16%)
     

  • 10-Yr Bond

    4.6510
    +0.0230 (+0.50%)
     

  • Nikkei

    38,471.20
    -761.60 (-1.94%)
     

  • Hang Seng

    16,248.97
    -351.49 (-2.12%)
     

  • FTSE Bursa Malaysia

    1,535.00
    -7.53 (-0.49%)
     

  • Jakarta Composite Index

    7,164.81
    -122.07 (-1.68%)
     

  • PSE Index

    6,404.97
    -157.46 (-2.40%)
     

U.S. states sue opioid-maker Indivior over alleged anticompetitive practices

Reuters

WASHINGTON (Reuters) - Thirty-five U.S. states and the District of Columbia filed a lawsuit on Thursday against opioid drug maker Indivior (INDV.L) alleging it tried to keep generic versions of a drug off the market.

British-based Indivior, which was spun off from Reckitt Benckiser (RB.L) in 2014, is the maker of Suboxone, a drug used to treat patients addicted to heroin and other painkillers.

The lawsuit by the states alleged that Indivior took steps to get patients to switch to a dissolvable oral strip version of Suboxone.

(Reporting by Sarah N. Lynch; Editing by Peter Cooney)